Parkinson’s Disease Gordon Research Conference
The Parkinson’s Disease Gordon Research Conference will focus on molecular mechanisms and their translation into human Parkinson’s disease research.
The 2027 meeting will examine developments in genetics, alpha-synuclein biology, neuroimmune mechanisms, lysosomal and proteostatic pathways, lipid and membrane biology, RNA biology, biomarkers and human-relevant disease models.
Sessions will connect molecular and cellular mechanisms with differences observed between patients. Topics will include disease initiation and progression, protein aggregation and co-pathology, endolysosomal and mitochondrial pathways, RNA-protein homeostasis, clinical cohorts and emerging biomarker frameworks.
The five-day programme is designed around scientific presentations, discussion and informal interaction, with dedicated poster sessions and networking opportunities. The conference will consider how research can support disease stratification, biomarker development, therapeutic target prioritisation and future clinical testing.
Where:
Rey Don Jaime Grand Hotel
Avinguda de l’Hotel
Castelldefels, Barcelona
Spain
When:
9–14 May 2027
Why attend?
- Explore research into the molecular and cellular mechanisms underlying Parkinson’s disease.
- Examine developments in genetics, biomarkers, alpha-synuclein biology and human-relevant disease models.
- Discuss how biological discoveries could inform disease stratification, therapeutic targets and future clinical testing.
- Present and discuss research through dedicated poster sessions.
- Connect with scientists at different career stages through scientific discussions, communal meals and informal networking.
EVENT WEBSITE:
https://www.grc.org/parkinson-s-disease-conference/2027/
ORGANISER:
Gordon Research Conferences
